Tallahassee Memorial Hospital

Summary

Tallahassee Memorial Hospital is a medical facility located in Tallahassee, Florida. This center is recognized for care of Breast Cancer, Lung Cancer, Coronary Artery Disease, Coronavirus, Brain Tumor and other specialties. Tallahassee Memorial Hospital is involved with conducting 109 clinical trials across 197 conditions. There are 6 research doctors associated with this hospital, such as Thomas Noel, MD, William Dixon, MD, Karen Russell, MD, and Ingrid Jones-Ince, MD.

Top PIs

Clinical Trials running at Tallahassee Memorial Hospital

Breast Cancer

Lung Cancer

Multiple Myeloma

Depression

Breast cancer

Thyroid Cancer

Prostate Cancer

Ovarian Cancer

Bladder Cancer

Leukemia

Mindfulness Approaches

for Living After Breast Cancer

NRG-CC015 is a prospective, randomized phase III clinical trial to evaluate the efficacy of two distinct digital approaches for delivering a mindfulness-based intervention: a live, instructor-led version delivered over Zoom (MAPs LO), and an app-based, self-paced version (MAPs App). Participants will include younger breast cancer survivors (BCS) who were diagnosed with breast cancer at or before age 50 years, have completed their primary cancer treatment (i.e., surgery, radiation, and/or chemotherapy) at least 6 months earlier, and report elevated depressive symptoms.

Recruiting

2 awards

Phase 3

5 criteria

Pembrolizumab

for Triple-Negative Breast Cancer

The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.

Recruiting

2 awards

Phase 3

19 criteria

Cognitive Training

for Breast Cancer Survivors

This Phase III trial will examine the efficacy of computerized cognitive training methods on perceived cognitive impairment in breast cancer survivors.

Recruiting

1 award

N/A

5 criteria